Oligonukleotīdu sintēze

Oligonukleotīdu sintēze is a public tender published 9 Dec 2025 by APP Latvijas Biomedicīnas pētījumu un studiju centrs, bids due 29 Dec 2025, estimated €41,000, status cancelled (EIS (Latvian Electronic Procurement System), as of 29 Sep 2026).

Source: EIS (Latvian Electronic Procurement System), retrieved 29 September 2026.

Contracting authority
APP Latvijas Biomedicīnas pētījumu un studiju centrs
Country
Latvia tenders (LV)
Status
cancelled
Source
EIS
Published
2025-12-09
Deadline
2025-12-29
Estimated value
€41,000
CPV
24950000-8 — Specialised chemical products
Category hubs
Chemical products
Original notice
View at source

Nr: BMC 2025/563 Procedūra: Mazie iepirkumi Profils: PIL_9_panta_kārtībā Priekšmets: Piegāde Vieta: Riga, Rātsupītes 1 k-1 (LATVIJA), LV-1067 Termiņš: 24 Vērtība: no 3000.00 līdz 41000.00 EUR Metode: Tikai zemākās cenas vai tikai izmaksu vērtēšana Kontakts: Oskars Zvejnieks,…

Frequently asked questions

What is the deadline for this tender?
Bids are due 29 December 2025.
What is the status of this tender?
The tender status is cancelled.

Full tender details (members only)

The following on this tender is available to signed-in TendeRadar users:

  • Full tender description & requirements
  • Tender documents & specifications
  • Why-it-fits matching for your company & market analytics

Sign in to see documents, participants & matching →